SPATA33

gene
On this page

Also known as FLJ31606

Summary

SPATA33 (spermatogenesis associated 33, HGNC:26463) is a protein-coding gene on chromosome 16q24.3, encoding Spermatogenesis-associated protein 33 (Q96N06). Plays an important role in sperm motility and male fertility.

Predicted to be involved in mitophagy. Predicted to act upstream of or within fertilization; flagellated sperm motility; and protein localization. Predicted to be located in male germ cell nucleus and sperm mitochondrial sheath. Predicted to be active in cytoplasm and nucleus.

Source: NCBI Gene 124045 — RefSeq curated summary.

At a glance

  • GWAS associations: 13
  • Clinical variants (ClinVar): 44 total
  • MANE Select transcript: NM_001271907

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26463
Approved symbolSPATA33
Namespermatogenesis associated 33
Location16q24.3
Locus typegene with protein product
StatusApproved
AliasesFLJ31606
Ensembl geneENSG00000167523
Ensembl biotypeprotein_coding
OMIM615409
Entrez124045

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 6 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000301031, ENST00000457689, ENST00000564238, ENST00000565890, ENST00000566204, ENST00000566857, ENST00000567827, ENST00000568929, ENST00000579310, ENST00000611218

RefSeq mRNA: 6 — MANE Select: NM_001271907 NM_001271907, NM_001271908, NM_001271909, NM_001271910, NM_001387226, NM_153025

CCDS: CCDS10983, CCDS62012, CCDS73929

Canonical transcript exons

ENST00000579310 — 3 exons

ExonStartEnd
ENSE000034899998965783689657948
ENSE000035702838965824889658421
ENSE000039200488966928689670458

Expression profiles

Bgee: expression breadth ubiquitous, 183 present calls, max score 97.72.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.0485 / max 350.0419, expressed in 1775 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1556326.32321744
1556304.69861384
1556310.02675

Top tissues by expression

246 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001997.72gold quality
left testisUBERON:000453397.13gold quality
right testisUBERON:000453497.11gold quality
testisUBERON:000047394.57gold quality
adult organismUBERON:000702393.37gold quality
pancreatic ductal cellCL:000207992.22silver quality
bronchial epithelial cellCL:000232890.19gold quality
right uterine tubeUBERON:000130289.95gold quality
bronchusUBERON:000218588.76gold quality
olfactory segment of nasal mucosaUBERON:000538686.89gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.27gold quality
cortical plateUBERON:000534382.65gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099182.21gold quality
ventricular zoneUBERON:000305382.04gold quality
prefrontal cortexUBERON:000045180.67gold quality
anterior cingulate cortexUBERON:000983580.56gold quality
right frontal lobeUBERON:000281080.21gold quality
ganglionic eminenceUBERON:000402379.99gold quality
Brodmann (1909) area 9UBERON:001354079.48gold quality
adenohypophysisUBERON:000219678.96gold quality
hypothalamusUBERON:000189878.91gold quality
small intestine Peyer’s patchUBERON:000345478.21gold quality
pituitary glandUBERON:000000777.77gold quality
mucosa of transverse colonUBERON:000499177.62gold quality
amygdalaUBERON:000187677.58gold quality
fallopian tubeUBERON:000388977.32gold quality
neocortexUBERON:000195077.14gold quality
metanephros cortexUBERON:001053377.08gold quality
dorsolateral prefrontal cortexUBERON:000983477.00gold quality
left lobe of thyroid glandUBERON:000112076.90gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-GEOD-134144yes30.71
E-CURD-114yes11.43
E-ANND-3yes6.69

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

41 targeting SPATA33, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-453199.9969.703181
HSA-MIR-1229-3P99.9766.49906
HSA-MIR-185-3P99.9567.011743
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-6835-3P99.9370.492904
HSA-MIR-3151-5P99.8663.831069
HSA-MIR-6756-5P99.8267.972466
HSA-MIR-92A-2-5P99.7567.012164
HSA-MIR-472999.6972.184233
HSA-MIR-6766-5P99.6867.702325
HSA-MIR-5197-5P99.6469.081494
HSA-MIR-451699.6167.783390
HSA-MIR-17-3P99.5566.771311
HSA-MIR-1212399.5271.792990
HSA-MIR-4735-5P99.4368.491780
HSA-MIR-664A-3P99.2271.082696
HSA-MIR-6815-3P99.1368.981530
HSA-MIR-443499.1067.011984
HSA-MIR-570399.1067.092053
HSA-MIR-6770-5P98.9766.761853
HSA-MIR-319698.9663.91326
HSA-MIR-315498.9466.551455
HSA-MIR-6829-5P98.8665.121480
HSA-MIR-548Q98.7165.35563
HSA-MIR-4700-5P98.6367.431915
HSA-MIR-318098.4664.68348
HSA-MIR-3180-3P98.4664.68348
HSA-MIR-6816-5P98.4664.35364
HSA-MIR-317998.2265.901445

Literature-anchored findings (GeneRIF, showing 1)

  • the current study illustrated that alterations in SPATA33 gene, at least those found in this study, may not impair spermatogenesis in patients with nonobstructive azoospermia. (PMID:30098056)

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Spermatogenesis-associated protein 33Q96N06 (reviewed: Q96N06)

All UniProt accessions (7): Q96N06, H3BQG0, H3BSG8, J3KRC8, J3KS00, J3KS58, J3KSB2

UniProt curated annotations — full annotation on UniProt →

Function. Plays an important role in sperm motility and male fertility. Required for sperm midpiece flexibility and for the localization of sperm calcineurin to the mitochondria. Promotes mitophagy as well as acts as an autophagy mediator in male germline cells. Links damaged mitochondria to autophagosomes via its binding to the outer mitochondrial membrane protein VDAC2, as well as to key autophagy machinery component ATG16L1.

Subunit / interactions. Interacts (via PQIIIT motif) with PPP3R1, PPP3R2, PPP3CA, PPP3CB and PPP3CC. Interacts with VDAC2. Interacts with ATG16L1 (via WD repeats).

Subcellular location. Cytoplasm. Cytosol. Nucleus. Mitochondrion.

Isoforms (2)

UniProt IDNamesCanonical?
Q96N06-11yes
Q96N06-22

RefSeq proteins (6): NP_001258836, NP_001258837, NP_001258838, NP_001258839, NP_001374155, NP_694570 (=MANE)

Domains & families (InterPro)

IDNameType
IPR027930DUF4609Family

Pfam: PF15382

UniProt features (12 total): region of interest 4, compositionally biased region 3, chain 1, splice variant 1, sequence variant 1, short sequence motif 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96N06-F166.260.07

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 94

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 65 (showing top): GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, GOBP_MACROAUTOPHAGY, NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOCC_MOTILE_CILIUM, GOCC_SPERM_MIDPIECE, GOCC_CILIUM, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_AUTOPHAGY_OF_MITOCHONDRION, GOBP_MITOPHAGY, BAKKER_FOXO3_TARGETS_DN, GOBP_PROCESS_UTILIZING_AUTOPHAGIC_MECHANISM, DELACROIX_RARG_BOUND_MEF, DELACROIX_RAR_BOUND_ES, GOCC_9PLUS2_MOTILE_CILIUM

GO Biological Process (2): mitophagy (GO:0000423), autophagy (GO:0006914)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (6): nucleus (GO:0005634), cytoplasm (GO:0005737), mitochondrion (GO:0005739), cytosol (GO:0005829), sperm midpiece (GO:0097225), sperm mitochondrial sheath (GO:0097226)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
intracellular membrane-bounded organelle2
cytoplasm2
autophagy of mitochondrion1
macroautophagy1
catabolic process1
transmembrane transport1
process utilizing autophagic mechanism1
binding1
intracellular anatomical structure1
sperm flagellum1
sperm midpiece1

Protein interactions and networks

STRING

244 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SPATA33DEF8Q6ZN54599
SPATA33SPMIP10Q6ZNM6560
SPATA33DBNDD1Q9H9R9557
SPATA33CDK10Q15131528
SPATA33SPIRE2Q8WWL2464
SPATA33KBTBD2Q8IY47447
SPATA33CENPBD1PB2RD01435
SPATA33SPATA2LQ8IUW3430
SPATA33CHMP1AQ9HD42399
SPATA33SYPL2Q5VXT5393
SPATA33VPS9D1Q9Y2B5386
SPATA33DPEP1P16444385
SPATA33SPESP1Q6UW49384
SPATA33MC1RQ01726371
SPATA33ZNF276Q8N554359

IntAct

21 interactions, top by confidence:

ABTypeScore
RUBCNBECN1psi-mi:“MI:0914”(association)0.920
PPP3CCSPATA33psi-mi:“MI:0915”(physical association)0.670
ACOT2ACOT1psi-mi:“MI:0914”(association)0.530
KCNE3RIOK3psi-mi:“MI:0914”(association)0.530
SPATA33AP1G1psi-mi:“MI:0914”(association)0.350
LBX2GGPS1psi-mi:“MI:0914”(association)0.350
ZNF492HPRpsi-mi:“MI:0914”(association)0.350
TCF15TCF4psi-mi:“MI:0914”(association)0.350
DTWD1ACTA2psi-mi:“MI:0914”(association)0.350
MTERF3ACOT4psi-mi:“MI:0914”(association)0.350
PPP3CAZNF593psi-mi:“MI:0914”(association)0.350
MAPTPITPNM1psi-mi:“MI:2364”(proximity)0.270
MAPTDCTN6psi-mi:“MI:2364”(proximity)0.270
MAPTpsi-mi:“MI:2364”(proximity)0.270
SPATA33PPP3CCpsi-mi:“MI:0915”(physical association)0.000

BioGRID (25): SPATA33 (Affinity Capture-MS), SPATA33 (Two-hybrid), PPP3CB (Affinity Capture-MS), SPATA33 (Affinity Capture-MS), AP1S2 (Affinity Capture-MS), AP1M1 (Affinity Capture-MS), PPP3CA (Affinity Capture-MS), SPATA33 (Affinity Capture-MS), SPATA33 (Affinity Capture-MS), SPATA33 (Affinity Capture-MS), SPATA33 (Affinity Capture-MS), AP1B1 (Affinity Capture-MS), AP1S1 (Affinity Capture-MS), SPATA33 (Affinity Capture-MS), PPP3CC (Affinity Capture-MS)

ESM2 similar proteins: A0A1B0GUA9, A0JNH1, A1L170, A2TJV2, A6H7B4, A6NFA0, A6NGY1, A6X8Z5, A7YY35, B2RQL2, D3Z1D3, M0RD54, P43359, Q05860, Q0VF49, Q1RMX6, Q1RN00, Q2M1Z3, Q32LI3, Q3URK1, Q5EBJ4, Q5M831, Q5RJL0, Q62100, Q640N3, Q64256, Q642A3, Q66H53, Q66LM6, Q68D20, Q68DA7, Q68US1, Q6AXN6, Q6AYA8, Q6IR42, Q711Q0, Q80VY2, Q86UF4, Q8IY42, Q8TDR4

Diamond homologs: Q8C624, Q96N06

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

44 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance38
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

511 predictions. Top by Δscore:

VariantEffectΔscore
16:89669284:A:AGacceptor_gain0.9900
16:89669285:G:GGacceptor_gain0.9900
16:89669285:GA:Gacceptor_gain0.9900
16:89669285:GAGA:Gacceptor_gain0.9900
16:89669285:GAGAA:Gacceptor_gain0.9900
16:89657836:G:GGdonor_gain0.9700
16:89669280:CTCTA:Cacceptor_loss0.9700
16:89669282:CTA:Cacceptor_loss0.9700
16:89669283:TA:Tacceptor_loss0.9700
16:89669284:A:ATacceptor_loss0.9700
16:89669285:G:GAacceptor_loss0.9700
16:89658419:AAGGT:Adonor_loss0.9600
16:89658421:GGTAG:Gdonor_loss0.9600
16:89658423:T:Gdonor_loss0.9600
16:89658419:A:Tdonor_gain0.9500
16:89658209:GGTA:Gdonor_loss0.9400
16:89658210:G:Adonor_loss0.9400
16:89658211:T:TCdonor_loss0.9400
16:89658210:G:GGdonor_gain0.9300
16:89663376:C:Gdonor_gain0.9200
16:89658213:AGT:Adonor_loss0.9000
16:89661398:T:Aacceptor_gain0.8900
16:89658242:TTTCA:Tacceptor_loss0.8800
16:89658243:TTCA:Tacceptor_loss0.8800
16:89658244:TCAGG:Tacceptor_loss0.8800
16:89658245:CAGG:Cacceptor_loss0.8800
16:89658246:A:Tacceptor_loss0.8800
16:89658247:G:GAacceptor_loss0.8800
16:89658247:GGT:Gacceptor_gain0.8800
16:89658241:ATTTC:Aacceptor_loss0.8700

AlphaMissense

916 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:89669340:T:CI88T0.995
16:89669340:T:GI88S0.994
16:89669459:A:CS128R0.992
16:89669461:T:AS128R0.992
16:89669461:T:GS128R0.992
16:89669346:T:AI90N0.985
16:89669346:T:GI90S0.983
16:89669412:T:CI112T0.978
16:89669340:T:AI88N0.976
16:89669449:C:AH124Q0.973
16:89669449:C:GH124Q0.973
16:89669334:C:AP86Q0.972
16:89669447:C:GH124D0.972
16:89669412:T:AI112N0.971
16:89669346:T:CI90T0.970
16:89669456:C:TP127S0.966
16:89669412:T:GI112S0.965
16:89669457:C:AP127H0.964
16:89669471:G:CA132P0.964
16:89669333:C:AP86T0.962
16:89669333:C:TP86S0.962
16:89669448:A:GH124R0.960
16:89669334:C:GP86R0.958
16:89669460:G:TS128I0.953
16:89669474:T:GY133D0.951
16:89669452:G:CR125S0.949
16:89669452:G:TR125S0.949
16:89669472:C:AA132D0.948
16:89669460:G:AS128N0.942
16:89669432:G:CG119R0.941

dbSNP variants (sampled 300 via entrez): RS1000034231 (16:89664295 G>A,C,T), RS1000251385 (16:89662835 C>G,T), RS1000335852 (16:89659132 C>G), RS1000388476 (16:89659228 G>A), RS1000680806 (16:89670391 A>G), RS1000876604 (16:89656743 G>C), RS1000887887 (16:89656207 G>A), RS1001135515 (16:89670244 C>T), RS1001600508 (16:89660470 G>T), RS1001806658 (16:89668198 G>C), RS1002005247 (16:89658177 C>A,G,T), RS1002060523 (16:89658332 A>G), RS1002319282 (16:89657314 G>C,T), RS1002373265 (16:89656890 G>C), RS1002488526 (16:89664058 G>A,T)

Disease associations

OMIM: gene MIM:615409 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

13 associations (top):

StudyTraitp-value
GCST001885_11Height9.000000e-07
GCST002785_3Facial pigmentation9.000000e-15
GCST003327_11Squamous cell carcinoma1.000000e-20
GCST004067_174Hip circumference adjusted for BMI9.000000e-07
GCST004067_76Hip circumference adjusted for BMI7.000000e-10
GCST004604_27Hematocrit7.000000e-11
GCST004615_108Hemoglobin concentration1.000000e-09
GCST007488_10Skin pigmentation traits3.000000e-08
GCST007927_52Medication use (beta blocking agents)2.000000e-11
GCST010083_322Hemoglobin levels3.000000e-22
GCST010703_280Brain morphology (MOSTest)2.000000e-15
GCST012020_135Serum metabolite levels3.000000e-11
GCST90002403_692Red blood cell count1.000000e-12

EFO canonical traits (7, from GWAS)

EFO IDTrait name
EFO:0008039BMI-adjusted hip circumference
EFO:0004348hematocrit
EFO:0004509hemoglobin measurement
EFO:0003963freckles
EFO:0009929Beta blocking agent use measurement
EFO:0004346neuroimaging measurement
EFO:0004305erythrocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases expression, affects expression3
trichostatin Aaffects expression1
beta-lapachonedecreases expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
di-n-butylphosphoric acidaffects expression1
abrinedecreases expression1
Sunitinibdecreases expression1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneaffects methylation1
Cadmiumincreases abundance, increases expression1
Cisplatindecreases expression1
Diethylhexyl Phthalatedecreases expression1
Methyl Methanesulfonateincreases expression1
Phthalic Acidsincreases methylation1
Quercetinincreases expression1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Triclosanincreases expression1
Valproic Acidincreases methylation1
Cadmium Chlorideincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): squamous cell carcinoma